C4A and neoplasm: Thus if c4 tumours have a low concentration of ATP, a PFK-1 inhibitor, they would be likely to have a high concentration of the PFK-1 activator AMP; both of these abnormalities would tend to activate PFK-1, thus enhancing glycolytic flux.